Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Obstetrics and Gynecology
|
May 10, 2003
Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency
J L Bartha, K Finning, P W Soothill
Vox Sanguinis
|
December 9, 2004
Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn
G Daniels, K Finning, P Martin, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
April 26, 2008
Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin
G Daniels, K Finning, P Martin, et al.
Transfusion Medicine (Oxford, England)
|
August 15, 2014
Anti-D prophylaxis: past, present and future
M de Haas, K Finning, E Massey, et al.
Early Human Development
|
January 20, 2007
Early detection of cell-free fetal DNA in maternal plasma
S Illanes, M Denbow, C Kailasam, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 22, 2014
Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
P W Soothill, K Finning, T Latham, et al.
Prenatal Diagnosis
|
December 2, 2006
Detection of cell-free fetal DNA in maternal urine
S Illanes, M L Denbow, R P Smith, et al.
Clinical Genetics
|
September 16, 2010
Non-invasive prenatal determination of fetal sex: translating research into clinical practice
M Hill, K Finning, P Martin, et al.
Vox Sanguinis
|
January 1, 1997
The serological profile and molecular basis of a new partial D phenotype, DHR
J W Jones, K Finning, R Mattock, et al.
Vox Sanguinis
|
December 17, 2008
Genotyping for red blood cell polymorphisms
C E van der Schoot, M de Haas, C P Engelfriet, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Obstetrics and Gynecology
|
May 10, 2003
Fetal sex determination from maternal blood at 6 weeks of gestation when at risk for 21-hydroxylase deficiency
J L Bartha, K Finning, P W Soothill
Vox Sanguinis
|
December 9, 2004
Fetal blood group genotyping from DNA from maternal plasma: an important advance in the management and prevention of haemolytic disease of the fetus and newborn
G Daniels, K Finning, P Martin, et al.
Transfusion Clinique Et Biologique : Journal De La Societe Francaise De Transfusion Sanguine
|
April 26, 2008
Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin
G Daniels, K Finning, P Martin, et al.
Transfusion Medicine (Oxford, England)
|
August 15, 2014
Anti-D prophylaxis: past, present and future
M de Haas, K Finning, E Massey, et al.
Early Human Development
|
January 20, 2007
Early detection of cell-free fetal DNA in maternal plasma
S Illanes, M Denbow, C Kailasam, et al.
BJOG : an International Journal of Obstetrics and Gynaecology
|
August 22, 2014
Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS
P W Soothill, K Finning, T Latham, et al.
Prenatal Diagnosis
|
December 2, 2006
Detection of cell-free fetal DNA in maternal urine
S Illanes, M L Denbow, R P Smith, et al.
Clinical Genetics
|
September 16, 2010
Non-invasive prenatal determination of fetal sex: translating research into clinical practice
M Hill, K Finning, P Martin, et al.
Vox Sanguinis
|
January 1, 1997
The serological profile and molecular basis of a new partial D phenotype, DHR
J W Jones, K Finning, R Mattock, et al.
Vox Sanguinis
|
December 17, 2008
Genotyping for red blood cell polymorphisms
C E van der Schoot, M de Haas, C P Engelfriet, et al.
Page
of 2